Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
194.4 USD | +0.15% | -0.25% | -24.77% |
12:00pm | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.77% | 28.22B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
+54.88% | 24.64B | |
-4.98% | 16.98B | |
-34.20% | 13.29B | |
-17.92% | 11.66B | |
-11.43% | 11.65B | |
-0.30% | 8.18B | |
+5.49% | 7.78B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- S&P Downgrades Biogen Rating To 'BBB+' From 'A-' On Declining Sales, Lower Growth Prospects, Outlook Stable